US Candida auris case count tops 600
Since its first identification in 2009 in Japan, C auris has triggered outbreaks in healthcare facilities in more than 20 countries and has shown resistance to three major antifungal drug classes. C auriscan cause serious invasive infections in patients who have compromised immune systems, and the CDC has estimated that 30% to 60% of patients with infections have died.
Join the AMR Insights Ambassador Network today!
Connect to over 650 AMR professionals and students in 65 countries!